closely monitored in APD patients in order to adjust PD prescriptions and maintain adequacy.
spectively over 1 year in two groups of peritoneal Introduction dialysis (PD) patients: 18 consecutive new patients starting on APD (12 continuous cyclic peritoneal diaFollowing the initial observations by Rottembourg [1], lysis (CCPD) patients and six nightly intermittent it is now recognized that residual renal function (RRF ) peritoneal dialysis (NIPD) patients) and 18 selected is better preserved in end-stage renal disease patients patients who had started on CAPD at the same time on continuous ambulatory peritoneal dialysis (CAPD) and were matched for baseline characteristics. RRF than in those on haemodialysis. This finding has been was assessed on normalized creatinine clearance recently reviewed and confirmed by Lameire [2] . (ml/min/1.73 mO) measured before the start of PD, at Good preservation of RRF is one of the main 6 months, and at 1 year. Wilcoxon's rank sum test was advantages of peritoneal dialysis (PD). RRF plays a used to compare differences between the two groups.
major role in maintaining water and electrolyte balance Results. Creatinine clearance (Cl Cr ) was 6.1 ml/min in without stringent food and water intake restriction, in the APD group and 6 ml/min in the CAPD group at maintaining renal endocrine function, and in eliminatthe start of PD. The monthly rate of Cl Cr decrease was ing so-called middle molecules. Beside these clinical significantly higher in the APD group: −0.28 ml/min vs benefits, RRF is one of the factors that determine −0.1 ml/min (P=0.04) at 6 months and −0.26 ml/min adequacy in PD patients. Consequently the length of vs −0.13 ml/min (P=0.005) at 1 year. RRF decreased time PD remains adequate depends on the rate at at the same rate in patients treated with NIPD or which RRF declines. The importance of RRF preserva-CCPD. The daily instilled volume of 3.86% glucose tion in PD patients has been confirmed by the dialysis solution ( l/day) was higher in APD patients CANUSA study, which found a link between PD than in CAPD patients: 2.5 vs 0 at 6 months and 1 patient outcome and adequacy indices [3] . The change year but there was no significant difference in ultrafilin these indices primarily resulted from a decrease in tration rate ( l/day) between APD and CAPD patients RRF over the course of that study. The importance of at these timepoints: 0.53 vs 0.6 and 0.88 vs 0.7 respect-RRF has been recently emphasized by Bargman et al. ively. There was no difference between the two groups who demonstrated that it is a predictor of patient in body weight and blood pressure, which remained survival on PD independently of PD dose [4] . stable in both groups throughout the study period.
Shortly after we expanded the use of automated Conclusions. RRF declined rapidly in APD patients peritoneal dialysis (APD) in our department, when whereas it was well preserved in CAPD patients. This second-generation home cyclers became available may be explained by the less stable fluid and osmotic (1995), we had the impression that some of our APD load together with the intermittent nature of APD and patients had an unusually rapid decline in RRF. We the larger use of hypertonic dialysate. RRF should be therefore undertook this study to investigate whether the good preservation of RRF previously reported in Correspondence and offprint requests to: Docteur Gilles Hufnagel, patients on CAPD was also observed in patients on 
Subjects and methods
median values and ranges and compared using the nonparametric Wilcoxon's rank sum test. Tests were two-tailed, From November 1995 to April 1997 we recruited a total of and a P value <0.05 was considered significant. 36 PD patients in a prospective study. RRF was determined and compared over 1 year of therapy in 18 consecutive new patients referred to our department to begin APD during Results this period (12 continuous cyclic peritoneal dialysis (CCPD) patients and six nightly intermittent peritoneal dialysis Table 1 shows a significantly greater RRF decrease in (NIPD) patients) and 18 selected new patients who had started on CAPD at the same time and were matched for APD patients than in CAPD patients at 6 months baseline RRF and underlying renal disease (glomerulo-(P=0.04) and 1 year (P=0.005). At the end of the nephritis in seven patients, polycystic kidney disease in four first year of treatment, median residual Cl Cr had fallen patients, nephroangiosclerosis and hypertension in three by 57% in APD patients as compared with 24% in patients, pyelonephritis in one patient, diabetes in two CAPD patients. In APD patients, RRF decreased patients, and unknown nephropathy in two patients, in each at the same rate in the NIPD and CCPD patient group). Despite not being matched for sex, both groups had subgroups.
the same sex ratio (11 males and 7 females in each group). Table 2 summarizes the time course of PD paraAge was 50±15 years (mean±SD) in the APD group and meters over the study period. Total daily dialysate 62±17 years in the CAPD group. At the start of PD, instilled volume and daily instilled volume of 3.86% furosemide (250-500 mg/day) was given to 17 patients in glucose dialysis solution were greater in APD patients each group. Angiotensin-converting enzyme inhibitors than in CAPD patients at 6 months and 1 year. There (ACEI ) were given to four patients in the APD group and was no significant difference in daily ultrafiltration two in the CAPD group.
Patient assignment to APD or CAPD was based upon volume between the two groups at 6 months and 1 their own choice after they had been fully informed about year. Weekly total Cl
Cr was significantly lower in APD each of these modalities. RRF was assessed on 24-h Cl Cr patients than in CAPD patients (P=0.01). There was measured just before the start of PD, at 6 months and 1 no difference in the 4-h dialysate to plasma creatinine year. Adequacy of PD was estimated at the same time-points ratio between the two groups at 6 months and 1 year.
by measuring weekly total Kt/V for urea and total Cl Cr . There was no difference between the two groups in Peritoneal Kt was estimated from 24-h dialysate urea excre-body weight and blood pressure, which remained stable tion and the serum urea concentration. Renal Kt was in both groups throughout the study period ( Table 3) .
estimated from the concurrent 24-h urinary urea excretion. Peritoneal Cl Cr was estimated from the 24-h dialysate creatinine excretion and the serum concentration at the completion Discussion of collection. Residual and peritoneal clearances were normalized to 1.73 mO body surface area and expressed as ml/min and l/week respectively. Standard peritoneal equilib-The results of our 1-year study confirm that RRF ration test (PET ), as described by Twardowski et al. [5] , decreases faster in patients on APD than in those on was also performed at the same time to estimate peritoneal CAPD, as first reported by Hiroshige et al.
[13], permeability. PET was done during a 4-h dwell with a 2.27% whose 6-month study suggested a negative influence of glucose dialysis solution and results were given as the dialys-APD technique on RRF. The monthly rate of creatinate-to-plasma ratio for creatinine at 4 h.
ine clearance decline in our APD patients was slightly
Peritoneal Cl Cr , urea Kt/V, and dialysate-to-plasma creati-higher than in their series: −0.40 ml/min vs −0.31 ml/ nine ratio were calculated using the computer-based kinetic min (Cl Cr values are given as the mean so as to compare modelling program PD AdequestTM version 1. All patients were treated with DianealR dialysis solutions in which glucose concentration was adjusted according to Creatinine clearance has been shown to overestimate the patient's need for ultrafiltration. All APD patients used GFR in end-stage renal failure patients because of an Home-ChoiceTM cyclers. Appropriate PD regimens were pre-increased tubular secretion of creatinine, but it is well scribed at the start of PD therapy and adjusted throughout correlated to inulin clearance [7] [8] [9] and is much simpler the study period so as to achieve a Kt/V for urea of 2.1 or to measure. Furthermore, most published studies of a total creatinine clearance of 70 l/week per 1.73 mO, as RRF have used this method to assess GFR in patients concluded in the CANUSA study. CAPD patients received receiving maintenance therapy [1,2,10-14]. We therethree to four 1.5-to 2.5-l exchanges per day. APD patients fore considered Cl Cr to be the appropriate marker to had one 8-to 10-h nightly session with 5-10 exchanges using compare our two groups of PD patients. PD parameters between the two groups were calculated at the groups. Indeed, it would have been desirable to Values are medians (ranges); no significant difference between the two groups.
determine the course of RRF decline in our patients aggressive the underlying disease. Such a hypothesis has never been confirmed by previous studies. Iest prior to the start of dialysis, but this was impossible because the patients had either been late referrals or et al. [11] reported that RRF was not affected by age in haemodialysed patients, and De Vecchi et al. [14] had been monitored on creatinine clearance calculated by the Cockroft and Gault formula, which does not also reported that residual Cl Cr was not affected by age after 1 year of CAPD, and moreover that allow for inter-subject comparison. Furthermore, the comparison of baseline characteristics shows that the elderly patients had a significantly lower RRF than did younger patients after 2 years of treatment. two groups were well-matched except for age, which was lower in the APD group than in the CAPD group. Furthermore, we compared the rate of RRF decline in four CAPD series of different ages (here again Cl Cr This was due to the fact that in our department most younger patients tend to chose APD because it allows values are given as the mean so as to compare them with those reported in the three other series): our them to remain active. Could this have introduced a selection bias by age? RRF would then be assumed to CAPD group (mean age=62), the series reported by Lysaght et al. (n=55, mean age 49) [12] and the two have declined more rapidly in younger patients simply because the earlier the onset of renal failure, the more series reported by De Vecchi (n=86, mean age 51.8 and n=63, mean age 76.5 respectively) [14] . Regardless of true both in NIPD, where solute and fluid are removed only at night, and in CCPD therapy, where intensive age, the mean monthly rate of RRF decline was similar in all four series, including our own: −0.14 ml/min, night sessions are supplemented by one or two additional long exchanges. Greater variations in fluid and −0.12 ml/min, −0.12 ml/min and −0.16 ml/min respectively. Such a comparison tends to demonstrate osmotic load may alter the haemodynamic status of these patients and potentially cause ischaemia, which that age is not a determining factor in the rate of RRF decline.
further damages glomerular filtration. This hypothesis has been suggested previously to account for the better The next question we may ask is whether or not the difference in RRF decline is a consequence of clinical preservation of RRF in CAPD patients than in haemodialysed patients [12] . It may also be that glomerular conditions that may have developed during the study period and adversely affected RRF. All patients main-filtration is affected by repeated exposure to a less biocompatible dialysis that would result from the tained a stable clinical course. No adverse event such as cardiac failure, uncontrolled hypertension, and higher exchange rate and hence the shorter time allowed for solute equilibration in APD. active systemic inflammatory disease was seen. The use of high-dose furosemide probably did not affect the Although the findings of our study need to be validated by further investigations, the observed rapid results of our study, since all but one patient in each group were given this drug. Moreover, whether routine RRF decline in APD patients requires that we remain cautious when proposing this technique. Special attenfurosemide helps preserve RRF remains speculative [2] . No patient was given ACEI after enrollment except tion should be paid to monitoring RRF in these patients in order to ajust PD prescriptions and those who had been treated with this medication before the start of PD therapy. Here again, the use of ACEI maintain adequacy.
Patients who choose APD should be informed that probably had no effect on the results of this study since the influence of this type of drug on RRF remains their RRF may decline more rapidly and that consequently their PD regimen may need to be modified doubtful in CAPD patients [12] . One patient in the APD group had two episodes of peritonitis and one accordingly to lengthen nightly sessions and/or to include additional daytime exchange(s) that may patient in the CAPD group had one episode. These episodes were treated as recommended for peritonitis impair their quality of life. related to peritoneal dialysis [15] . Neither of these two patients was given aminoglycosides. No patient received non-steroidal anti-inflammatory agents or any
